Amarin Corp plc (AMRN) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Price: $13.75 +2.00%
Financial Fact:
Loss on change in fair value of derivative liability: 3.61M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Loss on change in fair value of derivative liability: 3.61M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Amarin Corp plc (NASDAQ: AMRN) reported Q3 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13).
Recognized $14.1 million in product revenue from Vascepa® (icosapent ethyl) sales in Q3 2014 compared to $12.6 million in Q2 2014 and $8.4 million in Q3 2013, an increase of 12% and 68%, respectively
For earnings history and earnings-related data on Amarin Corp plc (AMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Talos Energy closes $420M Gulf of America deepwater asset deal
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
